Marma treatment and internal medicine for positional vertigo

Development of treatment protocol wrt marma chikitsa with karnapoorana and internal medication in bhrama wsr to benign paroxysmal positional vertigo - A pilot study - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059494

Enrollment

Registered

2023-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H811- Benign paroxysmal vertigo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient who are complaining with any signs and symptoms of BPPV Patients who are willing to participate in the study by giving informed consent

Exclusion criteria

Exclusion criteria: Vertigo caused by other than BPPV like meningitis encephelitis etc Individuals having high myopia and glaucoma Severe occular trauma Pregnant women Uncontrolled DM and HTN Mentally retarded patients Individuals having any secondary diseases like carcinoma tuberculosis

Design outcomes

Primary

Measure	Time frame
The efficacy of the marma chikitsa is assessed by seeing the reduction in the symptoms of positional vertigoTimepoint: baseline 25th day	—

Secondary

Measure	Time frame
Improving the quality of lifeTimepoint: baseline is 30 days	—

Countries

India

Contacts

Public ContactDr Adharsh Ganesh S K

KAHER SHRI BMK Ayurveda Mahavidyalaya

adharshganesh222@gmail.com9480486050

Outcome results